PSA
58
2
ROP
62
3
TXT
55
3
EBAY
47
4
IPG
56
3
HCA
44
-2
AA
48
-12
WY
54
4
PYPL
54
2
DG
6
2
TGT
22
2
VNO
60
10
HST
49
-9
HP
48
3
WAT
55
2
HBI
59
4
IR
66
3
MCD
52
2
HPE
63
2
EXC
53
-3
PSA
58
2
ROP
62
3
TXT
55
3
EBAY
47
4
IPG
56
3
HCA
44
-2
AA
48
-12
WY
54
4
PYPL
54
2
DG
6
2
TGT
22
2
VNO
60
10
HST
49
-9
HP
48
3
WAT
55
2
HBI
59
4
IR
66
3
MCD
52
2
HPE
63
2
EXC
53
-3
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

TGTX
TG Therapeutics

Last Price:
35.07
Seasonality Move:
52.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

TG Therapeutics Price Quote

$35.07

TG Therapeutics Key Stats

Buy
62
TG Therapeutics (TGTX) is a Buy
Day range:
$33.71 - $35.32
52-week range:
$12.30 - $36.50
Dividend yield:
0%
P/E ratio:
389.67
P/S ratio:
20.61
P/B ratio:
28.41%
Volume:
2.6M
Avg. volume:
3.7M
1-year change:
176.8%
Market cap:
$5.5B
Revenue:
$233.7M
EPS:
$-0.11

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.49%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.97%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 44.62% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 176.8% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $244.2M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $341M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.23

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$28.1M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $134.6M
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$61.6M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is -4.78%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -3.55%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is -8.4%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Inspire Medical Systems Inc (INSP)
    • Mirum Pharmaceuticals Inc (MIRM)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Varex Imaging Corp (VREX)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -97.26% -40.92%
Revenue: -49.41% 2.66%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 37.22
Upside from Last Price: 6.14%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    168.5M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22.1M TGTX shares are owned by insiders